Aatmaj Healthcare Ltd
Healthcare | Small Cap
Aatmaj Healthcare Ltd demonstrates a mixed financial performance. The company exhibits exceptional solvency and profitability, indicating a strong ability to meet long-term obligations and generate profits. Its liquidity position is also relatively strong, suggesting it can comfortably cover its short-term liabilities. However, the company's efficiency and growth metrics raise concerns, pointing to potential issues with asset utilization and inconsistent earnings. While revenue and asset growth are positive, declines in operating profit, EPS, and net income growth need attention. Overall, the company's strengths in solvency, liquidity, and profitability are somewhat offset by weaknesses in efficiency and inconsistent growth, indicating a need for strategic adjustments to optimize operational performance and ensure sustainable growth.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsUndervalued
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio4.80
- Financial Ratio3.60
- Profitability Ratio10.00
- Efficiency Ratio4.67
- Coverage Ratio8.40
- Solvency Ratio10.00
- Liquidity Ratio8.38
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursBullish
- 4 HoursBullish
- 1 DayNeutral
- 1 WeekBearish
- 1 MonthBearish
Aatmaj Healthcare Ltd demonstrates a mixed financial performance. The company exhibits exceptional solvency and profitability, indicating a strong ability to meet long-term obligations and generate profits. Its liquidity position is also relatively strong, suggesting it can comfortably cover its short-term liabilities. However, the company's efficiency and growth metrics raise concerns, pointing to potential issues with asset utilization and inconsistent earnings. While revenue and asset growth are positive, declines in operating profit, EPS, and net income growth need attention. Overall, the company's strengths in solvency, liquidity, and profitability are somewhat offset by weaknesses in efficiency and inconsistent growth, indicating a need for strategic adjustments to optimize operational performance and ensure sustainable growth.
Overall Valuation Score
P/E RATIO (TTM)
62.50
Industry Median
47.76
Small Cap Median
45.36
P/E RATIO
64.52
P/B RATIO
0.89
Industry Median
4.54
Small Cap Median
3.95
P/S RATIO
1.97
Industry Median
3.59
Small Cap Median
2.22
Others
PEG RATIO
-2.18
EV/EBITDA RATIO
13.52
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹20 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company demonstrates mixed growth performance. Revenue and asset growth are positive, driven by strong sales and asset expansion. However, operating profit, EPS, and net income growth have declined. The company needs to address declining profitability and earnings to ensure sustainable growth. Balancing revenue and asset growth with improved profitability is essential for long-term financial health.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 30.79 | 17.18 | -37.49 | 29.18 | 26.86 |
| Operating Profit Growth Rate | 41.97 | 30.89 | -74.06 | -39.22 | 52.26 |
| Earnings Per Share (EPS) Growth | 22.58 | -90.24 | -89.32 | -28.21 | 10.71 |
| Asset Growth Rate | 78.37 | 77.4 | 86 | 9.66 | 21.19 |
| Net Income Growth Rate | 22.57 | 17.03 | -85.11 | -27.27 | 10.94 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial metrics presents a mixed picture. Capital expenditures are well-managed, but adjusted EPS, cash EPS, book value per share, and dividend per share are not strong. The company needs to focus on improving earnings and shareholder value. Enhancing EPS and book value while maintaining reasonable capital expenditures is essential for improving overall financial performance.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 18.7 | 3.65 | 0.39 | 0.28 | 0.31 |
| Cash Earnings Per Share (Cash EPS) | 20.3 | 4.07 | 0.75 | 0.69 | 0.74 |
| Book Value Per Share | 30.63 | 8.75 | 21.89 | 22.18 | 22.49 |
| Dividend Per Share (DPS) | 0 | 0 | 0.05 | 0 | 0 |
| Capital Expenditures (CapEx) | 3.1 | 1 | 7.8 | 0.7 | 12.4 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company showcases excellent profitability, with high gross profit margin, ROCE, ROE, ROA, operating margin, and net margin. This reflects effective cost management and strong earnings generation. The company's profitability metrics demonstrate its ability to generate profits from its operations and investments. This strong profitability provides a solid foundation for future growth and stability.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 34.95 | 38.5 | 11.73 | 3.29 | 5.72 |
| Return on Capital Employed (ROCE) | 67.53 | 46.64 | 6.41 | 3.39 | 3.56 |
| Return on Equity (ROE) | 61.06 | 41.68 | 1.78 | 1.28 | 1.4 |
| Return on Assets (ROA) | 42.96 | 31.7 | 4.42 | 2.45 | 3.08 |
| Operating Margin | 37.07 | 41.41 | 17.18 | 8.09 | 9.7 |
| Net Margin | 24.93 | 24.89 | 5.93 | 3.34 | 2.92 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company demonstrates mixed efficiency. Inventory turnover and days sales in inventory are efficient, indicating effective inventory management. However, fixed asset turnover, receivables turnover, receivable days, and capital turnover are not as efficient. The company needs to enhance asset utilization and improve collection processes. Balancing inventory management with better asset and capital utilization is essential for improving overall operational efficiency.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 1.86 | 2.13 | 0.82 | 1.07 | 0.83 |
| Inventory Turnover Ratio | 42.52 | 36.05 | 25.19 | 27.47 | 19.94 |
| Receivables Turnover Ratio | 7.15 | 2.07 | 0.77 | 0.85 | 0.99 |
| Days Sales in Inventory Ratio | 8.58 | 10.12 | 14.49 | 13.29 | 18.3 |
| Receivable Days | 51.05 | 176.33 | 474.03 | 429.41 | 368.69 |
| Capital Turnover Ratio | 2.25 | 1.49 | 0.29 | 0.37 | 0.41 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company demonstrates strong capacity to cover its interest expenses, as indicated by the interest coverage ratio. However, the equity dividend coverage ratio is average, suggesting that dividend distributions are adequately covered by available equity. The company can comfortably manage its debt obligations. Balancing interest coverage with improved dividend coverage is important for maintaining financial strength.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 29.5 | 10.19 | 2.07 | 2.22 | 1.7 |
| Equity Dividend Coverage Ratio | 7.79 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's solvency position is excellent, with a low debt ratio and debt-to-equity ratio, alongside a high equity ratio. This indicates a strong financial structure with minimal reliance on debt. The company's assets are primarily funded by equity, providing a stable financial base. This robust solvency offers financial flexibility but it is important to maintain this balance to leverage growth opportunities without compromising financial stability.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.08 | 0.11 | 0.02 | 0.03 | 0.15 |
| Debt to Equity Ratio | 0.09 | 0.12 | 0.02 | 0.03 | 0.18 |
| Equity Ratio | 0.92 | 0.89 | 0.98 | 0.97 | 0.85 |
| Debt To Asset Ratio | 0.04 | 0.06 | 0.02 | 0.02 | 0.11 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position is strong due to high current and quick ratios, suggesting it can meet its short-term obligations. The ability to swiftly convert assets into cash is a positive sign. However, the operating cash flow ratio is weak, indicating potential difficulties in generating cash from operations. While current assets cover short-term liabilities, operational cash generation needs strengthening to ensure long-term financial flexibility.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 0.78 | 1.32 | 5.67 | 3.91 | 2.74 |
| Quick Ratio | 0.73 | 1.29 | 5.58 | 3.85 | 2.65 |
| Cash Ratio | 0.02 | 0.02 | 1.55 | 1.05 | 0.69 |
| Operating Cash Flow Ratio | 1.13 | 0.35 | -1.15 | 0.29 | 0.42 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Nidan Laboratories & Healthcare Ltd | 6.32 | 12.39 | Neutral | 4.84 | 1.08 | 1.51 |
| 2 | Aatmaj Healthcare Ltd | 6.29 | 64.52 | Undervalued | 2.36 | 0.32 | 0.71 |
The management effectiveness of Aatmaj Healthcare Ltd. presents a mixed picture. The company has demonstrated sales growth, and a consistent promoter holding. Declining profit growth and ROCE raise questions about the sustainability of the company's performance. Efficient working capital management is also a concern due to increasing debtor days and cash conversion cycle. Overall, the management exhibits both strengths and weaknesses.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth TTM | 32% | Positive sales growth indicates market traction |
| Promoter Holding | 63.74% | Consistent promoter holding suggests confidence | |
| CONS | Profit Growth TTM | -27% | Declining profit growth is a concern |
| ROCE | 3.39% | Low ROCE indicates poor capital efficiency |
Financial Performance & Growth
Aatmaj Healthcare demonstrates mixed financial performance. While sales growth is robust, profitability metrics raise concerns. The compounded sales growth shows a positive trajectory, but compounded profit growth shows a declining trend. Sales growth has been volatile, with significant fluctuations YoY. The operating profit margin (OPM) has also seen considerable variation, reflecting inconsistent operational efficiency. Despite revenue expansion, the ability to translate sales into profits appears to be inconsistent.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Sales | 4.13 | 15.49 | 20.26 | 23.74 | 14.84 | 19.53 |
| Sales Growth % | 275.06% | 30.79% | 17.18% | -37.49% | 31.60% | |
| OPM % | 16.22% | 34.15% | 37.07% | 41.41% | 17.18% | 7.94% |
Capital Efficiency & Returns
Capital efficiency and returns for Aatmaj Healthcare are generally weak. The ROCE has declined significantly. The ROE is also low, indicating that shareholder funds are not generating substantial returns. The trend indicates a deterioration in the company's ability to generate profits from its capital investments. This suggests potential inefficiencies in capital allocation and utilization.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| ROCE % | 63.84% | 67.53% | 46.64% | 6.41% | 3.39% |
| Return on Equity | 8% | 1% |
Financial Health & Prudence
Financial health and prudence are areas of concern for Aatmaj Healthcare. While the company has managed to maintain its dividend payout, there are concerns regarding its debt management. Debt/Equity Ratio has increased over the period. This indicates increasing financial risk and reliance on borrowed funds.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Borrowings | 8.76 | 4.33 | 5.18 | 11.69 | 5.47 | 10.06 |
| Equity Capital | 1.35 | 1.35 | 1.35 | 8.10 | 11.30 | 11.30 |
Shareholding & Ownership Structure
The shareholding and ownership structure of Aatmaj Healthcare presents a positive aspect. The promoter holding has remained consistent. This indicates confidence and alignment of interests between the management and the shareholders.
| Metric | Jun 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Promoter Holding | 63.72% | 63.72% | 63.72% | 63.72% | 63.74% |
The risk assessment for Aatmaj Healthcare Ltd. indicates moderate risk. The primary concerns arise from segment performance volatility and working capital management. the fluctuating segment performance and extended cash conversion cycle suggest potential operational and financial strains.
Segment performance volatility
Quarterly results indicate volatility in segment performance for Aatmaj Healthcare. The OPM % fluctuates significantly, ranging from -18.41% to 45.16%. This variability could be due to various factors, including changes in market conditions or internal operational challenges. Such fluctuations impact overall profitability and financial stability.
| Metric | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| OPM % | 34.13% | 38.21% | 45.16% | -18.41% | 4.82% | 10.34% |
Working capital management
Working capital management is an area of concern for Aatmaj Healthcare. Debtor Days have increased significantly over the years. The Cash Conversion Cycle has also lengthened, indicating inefficiencies in managing working capital. This may lead to liquidity issues and increased operational costs.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 86.61 | 13.43 | 91.88 | 274.13 | 507.16 | 459.38 |
| Cash Conversion Cycle | -343.07 | -116.99 | 91.88 | 274.13 | 507.16 | 349.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 1020.00Bearish
- SMA 2019.69Bullish
- SMA 5019.70Bullish
- EMA 1019.93Bullish
- EMA 2019.79Bullish
- EMA 5019.80Bullish
- DEMA 1020.08Bearish
- DEMA 2019.95Bullish
- DEMA 5019.60Bullish
- TEMA 1020.07Bearish
- TEMA 2020.13Bearish
- TEMA 5019.68Bullish
- MACD0.13Bullish
- ADX18.40Weak Trend
- IndicatorValueSignal
- RSI57.48Neutral
- CCI59.02Neutral
- ROC 9N/ABearish
- ROC 143.36Bullish
- ROC 255.26Bullish
- Stoch K100.00Overbought
- Stoch D100.00Overbought
- IndicatorValueSignal
- BB Upper20.49Neutral
- BB Middle19.69Neutral
- BB Lower18.89Neutral
- ATR0.14Low Volatility
- IndicatorValueSignal
- MFI100.00Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 1019.80Bullish
- SMA 2019.48Bullish
- SMA 5019.86Bullish
- EMA 1019.82Bullish
- EMA 2019.72Bullish
- EMA 5019.90Bullish
- DEMA 1020.02Bearish
- DEMA 2019.72Bullish
- DEMA 5019.62Bullish
- TEMA 1020.15Bearish
- TEMA 2019.95Bullish
- TEMA 5019.43Bullish
- MACD0.04Bullish
- ADX21.87Weak Trend
- IndicatorValueSignal
- RSI55.44Neutral
- CCI80.34Neutral
- ROC 93.36Bullish
- ROC 146.67Bullish
- ROC 252.56Bullish
- Stoch K100.00Overbought
- Stoch D100.00Overbought
- IndicatorValueSignal
- BB Upper20.46Neutral
- BB Middle19.48Neutral
- BB Lower18.50Neutral
- ATR0.24Low Volatility
- IndicatorValueSignal
- MFI100.00Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1019.44Bullish
- SMA 2019.70Bullish
- SMA 5020.29Bearish
- EMA 1019.73Bullish
- EMA 2019.79Bullish
- EMA 5019.95Bullish
- DEMA 1019.79Bullish
- DEMA 2019.56Bullish
- DEMA 50N/AN/A
- TEMA 1020.01Bearish
- TEMA 2019.57Bullish
- TEMA 50N/AN/A
- MACD-0.14Bullish
- ADX17.46Weak Trend
- IndicatorValueSignal
- RSI51.46Neutral
- CCI46.92Neutral
- ROC 95.26Bullish
- ROC 142.56Bullish
- ROC 250.76Bullish
- Stoch K56.82Neutral
- Stoch D53.54Neutral
- IndicatorValueSignal
- BB Upper20.87Neutral
- BB Middle19.70Neutral
- BB Lower18.54Neutral
- ATR0.49Low Volatility
- IndicatorValueSignal
- MFI75.51Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1019.70Bullish
- SMA 2020.29Bearish
- SMA 5019.94Bullish
- SMA 10020.99Bearish
- SMA 20020.38Bearish
- EMA 1019.78Bullish
- EMA 2019.96Bullish
- EMA 5020.23Bearish
- EMA 10020.47Bearish
- EMA 20020.99Bearish
- DEMA 1019.56Bullish
- DEMA 2019.72Bullish
- DEMA 5019.85Bullish
- DEMA 10020.20Bearish
- DEMA 20019.10Bullish
- TEMA 1019.59Bullish
- TEMA 2019.56Bullish
- TEMA 5019.72Bullish
- TEMA 10020.09Bearish
- TEMA 20020.81Bearish
- MACD-0.21Bearish
- ADX13.01Weak Trend
- IndicatorValueSignal
- RSI49.75Neutral
- CCI-23.57Neutral
- ROC 14-4.76Bearish
- ROC 25-3.38Bearish
- Stoch K43.61Neutral
- Stoch D27.89Neutral
- IndicatorValueSignal
- BB Upper22.22Neutral
- BB Middle20.28Neutral
- BB Lower18.35Neutral
- ATR0.89Low Volatility
- IndicatorValueSignal
- MFI61.26Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 2020.25Bearish
- SMA 5020.50Bearish
- EMA 2020.24Bearish
- EMA 5020.87Bearish
- DEMA 2019.86Bearish
- DEMA 5018.99Bullish
- TEMA 2019.57Bearish
- TEMA 5020.35Bearish
- MACD-0.32Bearish
- ADX13.52Weak Trend
- IndicatorValueSignal
- RSI45.92Neutral
- CCI-87.77Neutral
- ROC 14-2.78Bearish
- ROC 25-16.88Bearish
- Stoch K40.48Neutral
- Stoch D46.81Neutral
- IndicatorValueSignal
- BB Upper22.41Neutral
- BB Middle20.25Neutral
- BB Lower18.10Neutral
- ATR2.05Low Volatility
- IndicatorValueSignal
- MFI59.14Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 620.58Bearish
- SMA 1220.26Bearish
- SMA 2421.53Bearish
- EMA 619.99Bearish
- EMA 1220.67Bearish
- EMA 2424.74Bearish
- DEMA 619.62Bearish
- DEMA 1218.63Bullish
- DEMA 24N/AN/A
- TEMA 619.52Bearish
- TEMA 1219.84Bearish
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX35.55Strong Trend
- IndicatorValueSignal
- RSI30.01Neutral
- CCIN/AN/A
- ROC 25-47.79Bearish
- ROC 50N/AN/A
- Stoch KN/AN/A
- Stoch DN/AN/A
- IndicatorValueSignal
- BB Upper25.66Neutral
- BB Middle20.52Neutral
- BB Lower15.37Neutral
- ATR5.15Low Volatility
- IndicatorValueSignal
- MFI63.80Neutral